Skip to content

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05978128
Enrollment
800
Registered
2023-08-07
Start date
2023-07-28
Completion date
2029-09-30
Last updated
2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Carcinoma, Lung Carcinoma

Brief summary

This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.

Detailed description

PRIMARY OBJECTIVES: I. Determine the number of patients undergoing breast screening who are eligible to participate in lung screening. II. Determine whether patients currently participating in cancer screening (breast OR lung) are successful as cancer screening advocates. III. Determine whether laypersons who are aware of screening (including those who accompany friends and family members to their screening appointments) are successful as cancer screening advocates. IV. Identify knowledge base and psychological barriers to screening through surveys of potential screening participants. OUTLINE: Participants access an electronic patient portal with educational materials at baseline, 1- and 2-year follow-ups, and also interact with a patient navigator on study. Patients also receive materials to share with their friends/family on benefits of breast and lung cancer screening on study. After completion of study intervention, participants are followed up yearly for up to 3 years.

Interventions

BEHAVIORALHealth Education

Access electronic patient portal with educational material

OTHERHealth Promotion and Education

Receive materials on breast/lung cancer screening

BEHAVIORALPatient Navigation

Interact with a patient navigator

OTHERSurvey Administration

Ancillary studies

Sponsors

Jonsson Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: * Breast screening \> 40 * Lung screening 50-80 * Male (M) or Female (F) * Current, former, or never smokers * Close family or friend with smoking history (in or out of state)

Exclusion criteria

* Age: * Breast screening \< 40 * Lung screening \< 50 or \> 80 * Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded * Persons with an active cancer

Design outcomes

Primary

MeasureTime frameDescription
Increased rates of lung and breast cancer screening adherenceUp to 3 yearsBy following up with patients over the defined study period and assessing whether they obtained an incidence screen completed at one-year +/- 3 months from the recommended time. Will also measure the rates of survey completion by consented participants, the number of clicks and time spent reviewing educational materials, and the number of new participants who contacted the program through a referral by another participant.

Secondary

MeasureTime frameDescription
Success of sphere of influence modelUp to 3 yearsConsidered successful if increased lung cancer screening referrals are a direct result of women receiving screening mammograms inviting and educating friends and family about lung cancer screening.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026